SCHEMBL6202958

SCHEMBL6202958

CCCc1nc2ccc(NC(=O)CCc3ccc(C(F)(F)F)cc3)cc2c(N)c1CO

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6202397 0.82 MCHR1 (1.00) MCHR1
SCHEMBL6201768 0.77 MCHR1 (0.73) MCHR1
SCHEMBL6222066 0.76 MCHR1 (0.73) MCHR1
SCHEMBL6197863 0.74 MCHR1 (0.72) MCHR1
Hydrochloric Acid SCHEMBL5873618 0.74 MCHR1 (0.71) MCHR1
SCHEMBL5873520 0.74 MCHR1 (0.74) MCHR1
SCHEMBL5873590 0.72 MCHR1 (0.73) MCHR1
SCHEMBL6560040 0.72 MCHR1 (0.75) MCHR1
SCHEMBL5873754 0.71 MCHR1 (1.00) MCHR1
SCHEMBL5873636 0.70 MCHR1 (0.87) MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451156-A4 4-AMINOQUINOLINE COMPOUNDS MERCK & CO INC (US) 2005-05-25 EP claimed
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 US claimed
EP-1451156-A1 4-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP claimed
WO-2003045920-A1 4-AMINOQUINOLINE COMPOUNDS MERCK & CO., INC. (US) 2003-06-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R MCHR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.